Clinuvel Pharmaceuticals Limited (ASX: CUV)
Australia
· Delayed Price · Currency is AUD 13.04
-0.12 (-0.91%)
Nov 22, 2024, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 651.31 million as of November 22, 2024. Its market cap has decreased by -18.18% in one year.
Market Cap
651.31M
Enterprise Value
468.32M
Revenue
88.18M
Ranking
n/a
PE Ratio
18.68
Stock Price
13.04
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 651.31M, an increase of 12,363.60%. That is a compound annual growth rate of 22.49%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 133.87B |
| ResMed Inc. | 54.90B |
| Pro Medicus Limited | 22.43B |
| Fisher & Paykel Healthcare Corporation Limited | 20.33B |
| Cochlear Limited | 19.52B |
| Sonic Healthcare Limited | 13.43B |
| Ramsay Health Care Limited | 8.95B |
| Telix Pharmaceuticals Limited | 7.56B |